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Abstract
Illicit drug use has become popular in China. Acknowledging the challenge of illicit drug use, China has adopted
several new policies on the management of illicit drug use in recent years. This study reviews the current policies
on drug use and assesses the harm reduction interventions among drug users in China. The review documents
that the new policies on drug use provide a variety of choices of detoxification treatment for drug users. The
methadone maintenance treatment and needle exchange programs have been adopted as harm reduction models
in China. Most of the reviewed harm reduction programs have been successfully implemented and yielded positive
effects in reducing drug related risk behaviors among drug users. Although there remain barriers to the effective
implementation of policies on drug use and harm reduction programs, Chinese government has shown their com-
mitment to support the expansion of harm reduction interventions for drug users throughout the country.
Introduction
History of drug use in China
China has a long history of illicit drug use. Opium was
first trafficked into China by ancient Arabians in early
700 BC [1]. During the 16th century, British colonists
imported Indian opium into China as a means of
exchange for goods such as silk, tea and cash. Since
then, opium has been grown and used throughout
China [2]. The number of drug addicts exceeded 20 mil-
lion in 1949 when the new China was founded. Follow-
ing the launching of an extensive anti-drug campaign in
the early 1950s, the Chinese government news agency
announced in 1953 that drug abuse was completely
eliminated from the mainland, which led China to be
considered a drug-free country for the next thirty years
[2,3].
Drug use re-emerged in China as it adopted economic
reforms and an open door policy to the outside in
1980s. The drug trafficking activities were carried out
mainly through the route from the Golden Triangle
region (Myanmar, Yunnan and Guizhou provinces) to
Guangzhou and Hong Kong [4]. The large amount of
heroin and opium in the Chinese market has been
brought from Myanmar into Yunnan Province or from
Viet Nam into Guangxi Province [5]. According to the
World Drug Report in 2008, China had the third largest
heroin seizures in the world and the largest cocaine sei-
zures in Asia in 2006 [6].
According to the China Ministry of Public Security,
the number of registered drug users increased from
70,000 in 1990 to 1.16 million in 2005 [7,8], however,
the estimated number is believed to be higher [9]. The
majority of drug users use heroin. Most of them are
young, have little education and do not have stable
employment [10,11]. New drugs including ampheta-
mine-type-stimulants (ATS), particularly methampheta-
mine, and other narcotics have become popular among
youth since late 1990s and have since become available
in medium- and large- sized cities in China [9,12].
Brief overview of HIV/AIDS infection in injecting drug
users
The HIV epidemic in China began in 1989 among injec-
tion drug users (IDUs) [13]. Injection drug use (IDU)
was the major HIV transmission route in the country,
with cases of HIV/AIDS diagnosed among drug users in
all 31 provinces, municipalities and autonomous regions
by 2002 [14]. According to a recent estimate, 44.7% of
50,000 new HIV cases in 2007 were infected through
heterosexual contact, and 42% through IDU [15]. The
latest estimate of HIV prevalence among IDUs is 12.55%
[16]. However, HIV infection varies from region to
region. The HIV infection rates among IDUs in
* Correspondence: leejianhua77@gmail.com
1Yunnan Institute for Drug Abuse, Yunnan, China
Li et al. Harm Reduction Journal 2010, 7:4
http://www.harmreductionjournal.com/content/7/1/4
© 2010 Li et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.Xinjiang, Guangxi and Sichuan provinces are 41.31%,
16.95% and 15.12% respectively; whereas, HIV infection
rates among IDUs in Xingjiang and Yunnan province
reached to 52.51% [16]. As the number of drug users
continues to increase and the HIV epidemic continues
to spread in this population, IDU remains the major
cause of HIV infection [17].
Despite that the Chinese government has enacted sev-
eral policies and programs in response to drug users
and HIV prevention, the review of these policies and
related harm reduction programs has not been thor-
oughly conducted. The purpose of this paper was to
review the current policies against drug use and harm
reduction programs in China. The results of the review
will not only provide information for the Chinese gov-
ernment to better respond to the HIV epidemic among
drug users, but also provide recommendations for future
research
Methods
The following criteria were used in the review: (1) stu-
dies written in English and published in international
peer-reviewed journals between 1990 and 2008, (2)
harm reduction intervention studies among drug users
in mainland China and (3) related government policies
on illicit drug abuse and HIV intervention programs.
Relevant intervention studies were obtained using the
following databases: Pubmed, Medline, EBSCO and
Google Scholar. The combinations of key words used to
identify relevant articles included: China, HIV, AIDS,
drug use, narcotic control, incarceration, voluntary
counseling and testing and harm reduction intervention.
Results
Current policies regarding drug use and HIV prevention
among drug users
In 1990, the Standing Office of National People’sC o n -
gress enacted “Regulations on Prohibition against Nar-
cotics” which specified three levels of management. In
the first, drug users are fined and/or encouraged to
receive treatments in voluntary detoxification centers
managed by the Ministry of Public Health [18]. They
usually stay in the centers for 7-30 days [7,19]. Those
w h oh a v eg o n et h r o u g ht h ef i r s tl e v e la n dr e l a p s ea r e
sent to compulsory detoxification centers administered
by the Public Security Bureau (second level) [5,7,19-22].
They spend at least 6 months in the compulsory detoxi-
fication centers where they participate in a combination
of detoxification treatment, physical exercise, and man-
ual labor [7,19-22]. At the third level, drug users who
relapse after receiving compulsory detoxification are
mandated to 2 to 3 years of re-education through activ-
ities in labor camps administered by the Justice Bureau
[19,21,23]. As drug users are not allowed to leave the
compulsory detoxification centers and labor camps, they
are considered incarceration sites.
As stated in the “Regulations on Prohibition against
Narcotics”, the main purpose of the compulsory and
voluntary detoxification is to reduce demands for drug
use, drug related crimes, and injection drug use, which
are designed to eventually reduce HIV transmission
rates [21]. The Ministry of Health has issued guidelines
on the selection of detoxification medicines, but the
actual treatment regime and quality of the treatment
vary across centers. Psychosocial counseling and beha-
vioral intervention services for drug users are largely
unavailable in the detoxification centers, mainly because
they do not have enough professional staff and funding
to provide these services, especially at the city or county
level. Police and medical staff lack the knowledge and
skills for delivering harm-reduction and behavioral-
change counseling. Police often apply military manage-
ment approaches to treat drug users while they are in
incarceration sites. The majority of treated drug users
relapse and do not change their HIV risk behaviors after
they leave incarceration sites [21].
In 2006, the Chinese Ministry of Public Security
issued a policy program called “ The treatment of
arrested drug users in Compulsory Detoxification Cen-
ters”. According to this policy, newly-found drug users
were sent directly to compulsory detoxification centers,
while relapsed drug users were to reeducation labor
camps [24]. The Ministry of Public Security and the
Department of Public Security at the provincial and city
levels initiated a nationwide crackdown on drug use and
an intensified compulsory detoxification program for
drug users. In June 2006 alone, 269,000 drug users were
incarcerated and 71,000 of them were sent to reeduca-
tion labor camps [24]. At the end of 2006, there were
about 1000 incarceration sites in China. Over 600,000
drug users have been admitted to incarceration sites,
95% of whom were heroin users and 3% were opium
users (Jian, unpublished data).
The newly-promulgated “Narcotic Control Law” that
took effect on June 1, 2008 [25] had significant reforms on
the management of drug abuse in China. The new law
defines a clear leadership system, and a working mechan-
ism and supporting system for narcotics control. It speci-
fies that narcotics control is the responsibility of the whole
society, including governmental agencies at all levels and
all Chinese people. The law requires the State Council to
establish the National Narcotics Control Commission, and
the local governments at or above the county level to set
up a narcotics control committee which organizes, coordi-
nates and guides narcotics control activities in their juris-
dictional areas. The establishment of the commission and
the committees demonstrates that the Chinese govern-
ment has intensified its efforts to curb drug abuse. In
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cation treatment system, the new law prioritizes preven-
tion and intervention activities in association with
comprehensive drug control models and simultaneous
efforts to ban the cultivation, production, trafficking, and
abuse of drugs. The law introduces significant reforms on
drug treatment and rehabilitation in accordance with the
human-oriented principle. According to the new law, drug
users are not required to stay in detoxification centers,
rather, they have the right to select treatment or/and other
services from authorized institutions that provide these
services. In addition, the law also orders that drug users’
rights be protected. They have the same rights to educa-
tion, jobs, and social support [25].
In confronting the HIV/AIDS epidemic, China has
adopted the methadone maintenance treatment (MMT)
and needle exchange program (NEP) as harm reduction
models. The Five Year Action Plan to Control HIV/AIDS
2006-2010 issued by the Ministry of Health included
both MMP and NEP [23]. Methadone treatment has
been used as a detoxification method in China since
1993 [23], but its use was limited to inpatients in well-
equipped institutions [26]. Recognizing the efficacy of
MMT for drug dependence, China supported the use of
MMT to palliate HIV transmission in 2004 [27-29]. The
first eight government-supported pilot MMT clinics
were established in five provinces in early 2004 [23,30].
The program has since grown to 320 clinics, serving a
total of 27,000 heroin users in 22 provinces [28]. By
November 30, 2008, 558 MMT clinics had been put
into operation in 23 provinces, autonomous regions, and
municipalities, serving more than 170,000 clients [31].
The NEPs were first initiated by non-governmental
organizations (NGOs) and other international donors
rather than by the Chinese government because of the
concern that these programs condoned illicit drug use
[32]. When first introduced in China, NEPs were called
social marketing of needle exchange, which aimed to
promote commercial availability and accessibility of nee-
dles in combination with health education about safe
injecting practice, a concept approved by the Ministries
of Health and Pubic Security because it did not expli-
citly mention needle exchange or free needle distribu-
tion [28,33]. Acknowledging the growing research
evidence of successful NEPs in other countries, the Min-
istry of Health officially funded the first pilot NEP in
Guangxi and Yunnan province in 1999 [23,27,28]. The
program has expanded to other parts of China, with a
total of 790 needle exchange centers, 392 of which were
funded by the government in 2006 [34]. The Chinese
central government incorporated NEPs into the second
five-year action plan for HIV intervention (2006-2010)
and mandated that enough NEP sites be established to
serve at least 50% of the IDU population by 2010 [34].
Results of harm reduction interventions and HIV
prevention among drug users in China
The results of the empirical studies [5,35-41] in China
revealed that most of the interventions on harm reduc-
tion (e.g. MMT and NEP) and HIV prevention (e.g.
VCT) were successful and had positive effects in redu-
cing drug related risk behaviors among drug users in
both institution-based and community-based programs.
For example, two MMT intervention studies showed
that the use of MMT decreased the frequency of IDU
and criminal behaviors [37]. Three needle related studies
revealed a significant reduction of needle-sharing among
drug users [40,41] and a decline of new drug injectors
in the follow-survey [39]. Results of VCT studies docu-
mented that participants increased their HIV/AIDS
knowledge [35], increased condom use with regular and
casual sex partners, and decreased needle-sharing [36].
Two HIV knowledge-oriented studies have shown that
participants, after receiving the intervention, increased
their HIV-related knowledge, their understanding of
HIV prevention methods, and indicated positive atti-
tudes toward those with HIV/AIDS [38,42]. These posi-
tive results are consistent with the large body of
empirical evidence on effectiveness of harm reduction
programs in other countries [43-49].
Discussion
China has made substantial progress in the development
and implementation of policies on the management of
drug use and on effective intervention strategies for
HIV/AIDS in the past few years [27]. The newly-enacted
Narcotic Control Law is a milestone in harm reduction
and HIV prevention initiative. With the hierarchical
authority system in China, the new law would be quickly
enacted at different administration levels, ushering in a
new era of drug management and HIV intervention in
both community level and incarceration sites in the
world’s most populous nation.
Given the positive effects of MMT among drug users,
China is offering long-term use of MMT to palliate HIV
transmission in 2004 [27-29]. However, the conflicting
approach between “zero tolerance” policies toward drug
use and harm reduction programs [23], increasing the
demand for care, support and treatment for IDUs to
reach those in need [31] and a lack of cooperation
among departments at local levels (e.g., at the county
level or below) may make it difficult for the effective
implementation of harm reduction programs [50]. A
synchronized drug use control approach, open commu-
nication and strong cooperation among involved govern-
mental departments are needed to ensure the effective
implementation of the harm reduction initiatives in
China. As a substantial number of drug users are incar-
cerated and a proportion of them are HIV positive,
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incarceration centers to prevent further spread of HIV.
The new Narcotic Control Law demonstrates China’s
changed approach toward drug users. It reflects a
humane and people-first principle and provides a variety
of choices of detoxification treatment for drug users.
The implementation of this law requires not only strong
central government support, multi-sectoral participation
and collaboration, but also a strong commitment from
the local authorities. The central government needs to
provide clear guidelines for implementation of the new
law and make sure that these guidelines are strictly fol-
lowed by all local governments. While the new law
offers a comprehensive approach toward drug use, no
empirical evidence on the effectiveness of its implemen-
tation has been available. Evaluation of its effectiveness
needs to be conducted.
Despite attempts by the Chinese central government
to include NEPs into the second five-year action plan
(2006-2010) (State Council of P.R. China, unpublished
data), NEPs have not been fully supported by all govern-
mental agencies. The Ministry of Public Security does
not support the implementation of NEPs [27]. This per-
spective has created a challenge for public health work-
ers who implement NEPs at the local levels [5]. The
central government should coordinate different minis-
tries and departments to work on this conflict. The sus-
tainability and effectiveness of NEPs program can only
be obtained if there is full support from all participating
government agencies in China.
At the program level, findings of the review of NEPs
revealed that there remain barriers to access to NEPs
including the long distance to NEP sites, difficult access
to the service, and fear of being arrested when receiving
new needles [41]. Therefore, not only the coverage of
NEPs should be expanded, but also drug users must be
assured that it is safe to receive needles and that they
should not fear of the arrest by police. The Public
Security Bureau at local levels should be made aware of
evidence demonstrating the positive effects of NEPs in
reducing HIV transmission among IDUs and that NEPs
do not increase drug use [44,45,51].
Although the government has mandated that 50% cov-
erage of injection drug users by NEPs, the coverage tar-
get is insufficient. Several studies show that low syringe
coverage can severely affect the effectiveness of NEPs
[52,53]. For example, lack of syringe coverage might
have contributed to the limited effectiveness of NEPs in
Montreal [53]. Therefore, the government should
increase higher syringe coverage targets for injection
drug users and allocate funding for NEPs in the annual
budget plan.
Available literatures show that peer education plays an
effective role in the harm reduction programs [54,55].
Although peer education has been conducted success-
fully in a number of areas in China, most of the inter-
ventions have been restricted to small locally based
programs [56,57]. Large-scale peer education programs
have not been conducted [58]. Therefore, the govern-
ment should not only support for the development of a
national education program, but create favorable envir-
onments for the program implementation.
The existing intervention programs are largely run by
government agencies. NGOs in China should be encour-
aged to actively participate in drug and HIV interven-
tion programs. Only one VCT intervention study among
drug users has been successfully implemented by an
NGO and published in China so far [36]. The success of
this NGO-led intervention program suggests that harm
reduction programs delivered by NGOs should be
expanded in China. NGOs have advantages in drug and
HIV intervention over government agencies as they are
able to reach out high risk groups (e.g. IDUs or sex
workers) without making them fear of arrest or stigmati-
zation [18]. Experiences from other countries demon-
strate that NGOs play an important role in controlling
and preventing HIV/AIDS [59,60].
Although results of the available studies are encoura-
ging, few studies reported the application of a theoreti-
cal framework for the intervention programs. Studies
from other countries have demonstrated that theory-
based intervention programs have proven effective in
reducing HIV related risk behaviors among drug users
[61,62]. A recent review of HIV behavioral interventions
for a US high-risk population in 2000-2004 found that
all best-evidence interventions relied on at least one
behavioral change theory or model [63]. Further empiri-
cal evidences have shown that adding behavioral inter-
vention (e.g. VCT, health education and health
promotion) components into NEP and MMT programs
results in reducing injecting-related risk practices (e.g.
sharing needles), and decreasing high-risk sexual beha-
viors (e.g. unprotected sex) [64-67]. Theory-based harm
reduction interventions are recommended to promote
behavior change among drug users in China. Psychologi-
cal and behavioral counseling services should be integ-
rated with existing harm reduction programs.
Conclusions
The Chinese government has made significant progress
in evolving the policy on drug abuse. Policies on harm
reduction and HIV intervention have been improved
and enhanced based on the findings from research and
practices. This review demonstrates that harm reduction
programs have been successfully implemented in most
cases and yielded positive effects in reducing drug
related risk behaviors among drug users in China. This
evidence serves as an important resource for advocating
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among this population. Despite the fact that there
remain challenges, China is increasingly adopting scien-
tific evidence-based approaches and has encouraged the
pilot testing of methods of risk reduction [27]. This
increasing use of scientifically validated evidence
together with supportive policy on harm reduction pro-
grams, demonstrates not only the Chinese government’s
continuing commitment and determination in the fight
against HIV, but also the importance of future interven-
tion research in China.
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